Skip to main content
All resources
Buyer's Guide•7 min read•November 6, 2026

Evaluating Clinical Evidence for Aesthetic Devices: Reading FDA Clearances and Manufacturer Data

A sales conversation about a new laser or RF platform will typically reference three different kinds of evidence in the same breath: an FDA clearance, a clinical study, and a performance claim printed on a brochure. Practice owners are rarely trained to distinguish between them, and the distinction matters. Each type of evidence answers a different question, was tested under different conditions, and carries a different weight when something goes wrong or when a patient asks why a particular device was chosen for their treatment plan.

This article is not a substitute for regulatory or legal counsel, and it does not evaluate any specific device's clinical performance. It is intended to give buyers a working framework for reading the documents and data they are handed during an evaluation, so that purchasing decisions rest on an accurate understanding of what has actually been demonstrated rather than on the confidence of the presentation.

What a 510(k) Clearance Actually Confirms

The majority of aesthetic lasers and RF systems sold in the United States reach the market through the FDA's 510(k) pathway, which requires a manufacturer to demonstrate that a new device is substantially equivalent to an already-cleared predicate device in terms of intended use and technological characteristics. It is a safety and equivalence review, not an efficacy trial, and understanding that distinction is the single most useful thing a buyer can take away from this process.

  • Clearance is based on comparison to a predicate device, not on independent proof that the new device performs a treatment effectively
  • The review covers safety and substantial equivalence, not comparative performance against other cleared devices
  • The indications for use statement, not marketing language, defines the legal boundaries of what the device is cleared to do
  • A clinical trial is often not required for 510(k) clearance; bench testing and predicate comparison may be sufficient
  • Clearance applies to a specific device configuration and intended use, not to every application a sales team may describe
  • Class II devices, which include most aesthetic lasers and RF systems, typically follow this pathway rather than the more rigorous premarket approval process

What "FDA-Cleared" Does Not Tell a Buyer

Because clearance is binary, a device is either cleared or it is not, it provides no ranking of quality, output consistency, or outcome likelihood relative to other cleared devices in the same category. Two platforms can share an identical indication for use and differ substantially in software, handpiece design, energy delivery, or documented parameters. Treating clearance status as a proxy for performance is a common and avoidable error.

  • Clearance does not rank devices against competitors or endorse comparative superiority claims
  • It does not guarantee a particular clinical result for any individual patient
  • The clearance letter and indications for use are public and searchable in the FDA's 510(k) database, and are worth reading directly rather than relying on a summary
  • Off-label use of a cleared device is legal under physician judgment but falls outside the manufacturer's tested and documented intended use
  • A device cleared for one narrow indication is sometimes marketed more broadly than the clearance supports
  • Identical indications on two devices do not mean identical technology, output, or clinical protocol

Reading Manufacturer-Sponsored Clinical Data

Manufacturers frequently commission or sponsor clinical studies, white papers, or case series to support a product launch, and this data can be genuinely useful when evaluated with the right context. Sponsorship alone does not invalidate findings, but it does mean the study design, sample size, and reporting choices deserve scrutiny before the results are treated as generalizable.

  • Sample size and whether the study was designed and powered to detect a statistically meaningful difference
  • Whether outcomes were assessed by a blinded third party or by the treating investigator alone
  • Whether the work was peer-reviewed and published, or distributed only as an internal white paper or conference poster
  • Whether conflicts of interest and funding sources are disclosed in the document itself
  • Whether the study population reflects a range of Fitzpatrick skin types relevant to the buyer's own patient base
  • Whether treatment parameters, device settings, and protocol are disclosed in enough detail to be reproduced

Peer-Reviewed Literature: Strengths and Limits

Peer review adds a layer of scrutiny that internal marketing materials do not receive, and published literature should generally be weighted more heavily than unreviewed company documents. That said, peer review is not a guarantee of certainty, and aesthetic device literature carries well-documented limitations that buyers should keep in mind before extrapolating a published finding to their own practice.

  • The device or software version studied may differ from the current production model being purchased
  • Sample sizes in aesthetic device literature are frequently small relative to other areas of medicine
  • Publication bias favors positive results, so the absence of negative studies does not mean none exist
  • Findings on one manufacturer's device at a given wavelength do not automatically transfer to a different device operating at the same wavelength
  • Independent, non-sponsored replication of aesthetic device studies is relatively uncommon
  • Long-term follow-up data, beyond several months, is often limited or absent

Questions to Ask a Manufacturer Before Relying on a Claim

The due diligence conversation with a manufacturer's clinical or sales team is where most of this gets sorted out in practice. A manufacturer that designs and documents its own technology should be able to answer these questions directly, with source documents, rather than redirecting to general marketing collateral.

  • Can you provide the FDA clearance letter and the exact indications for use language on file
  • What specific device settings and protocol were used in the study being cited
  • Was the study independently conducted, or sponsored and designed by the manufacturer
  • What Fitzpatrick skin types and sample size were represented in the study population
  • Is there a peer-reviewed citation available, or only an internal report or conference abstract
  • How does the device's documented intended use compare to the way it is being marketed to my practice

Where to Draw the Line Between Evidence and Enthusiasm

Marketing language is not inherently dishonest, but it operates under different rules than regulatory submissions or published research, and a buyer who cannot tell the two apart is exposed both clinically and in terms of what can accurately be told to a patient during consent. A short list of red flags tends to catch most of the problem claims encountered during an equipment search.

  • Absolute or permanent language used without qualification or reference to individual variation
  • Before-and-after photography presented without disclosed treatment parameters, device, or number of sessions
  • Marketing claims that extend beyond the device's actual indications for use statement
  • "Clinically proven" language with no accompanying citation that can be independently located and read
  • Head-to-head comparison claims against named competitor devices without an actual comparative study behind them
  • Patient testimonials presented or formatted as if they were clinical data

WONTECH designs and manufactures its own laser and RF platforms in-house, including the OLIGIO X next-generation monopolar RF platform built on advanced monopolar radiofrequency technology, the SANDRO DUAL 755nm and 1064nm system, the V-LASER 532nm KTP and 1064nm Nd:YAG platform, and the PASTELLE PRO, PICO MAJESTY, and PICO ALEX picosecond and Q-switched systems, and supports the US market directly from Livermore, California. A practical next step for any practice working through this kind of evaluation is to request a demonstration and ask to see the clearance documentation and supporting data directly, rather than relying solely on summary materials.

This article is provided for educational purposes for licensed medical professionals and practice owners and does not constitute medical, legal, or regulatory advice. Clearance status, indications for use, and supporting data are device-specific and change over time, and individual treatment outcomes vary by patient and provider judgment. Readers should consult the manufacturer's current instructions for use, their state board regulations, and qualified legal counsel before making purchasing or clinical decisions, and scheduling a demonstration remains a practical way to evaluate a device directly.

Share

The New Standard Where Innovation Meets Beauty

Whether you’re a practitioner evaluating your next platform or a patient looking for a provider near you, we’re ready to help.